Introduction The prevalence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1/2) infection is heterogeneous across different populations. We tested the hypothesis that HTLV-1/2 infection occurs more often in dermatological patients. Methods A total of 1,091 patients from a tropical dermatology clinic were tested for HTLV-1/2. In parallel, 6865 first-time blood donors from the same geographic area were screened for HTLV-1/2; HTLV-1/2 positive blood donors underwent dermatological examinations. Results The prevalence of HTLV-1/2 in first-time blood donors was 0.14%. No co-occurrence of HTLV-1/2 infection and dermatological conditions was observed. Conclusions Our results challenge the hypothesis that HTLV-1/2 infection occurs more o...
Human T-lymphotropic virus type 1 (HTLV-1) is found in indigenous peoples of the Pacific Islands and...
Human T-lymphotropic virus type 1 (HTLV-1) is found in indigenous peoples of the Pacific Islands and...
BACKGROUND: There is difficulty in gathering data on the prevalence of human T-cell lymphotropic vi...
Introduction The prevalence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1/2) infection is...
Abstract. Dermatologic manifestations are quite common in patients with adult T cell leukemia/lympho...
Human T-lymphotropic virus type 1/2 (HTLV-1/2) infection is endemic in Brazil but representative don...
It is unknown whether HTLV-1/2 prevalence has been stable or changing with time in Brazil. We presen...
Background: Human T-cell lymphotropic virus type 1 (HTLV-1) infection can increase the risk of devel...
Abstract Human T-lymphotropic virus (HTLV) infection has a worldwide distribution and currently, mor...
Background Human T-cell lymphotropic virus type 1 (HTLV-1) infection can increase the risk of develo...
Background. Infective dermatitis associated with human T-cell lymphotropic virus type 1 (HTLV-1; IDH...
Salvador (BA, Brazil) is an endemic area for human T-cell lymphotrophic virus type 1 (HTLV-1). The o...
Salvador (BA, Brazil) is an endemic area for human T-cell lymphotrophic virus type 1 (HTLV-1). The o...
p.761-764Salvador (BA, Brazil) is an endemic area for human T-cell lymphotrophic virus type 1 (HTLV-...
Introduction: Brazil has a high number of HTLV-1/2 infections which are unequally distributed in the...
Human T-lymphotropic virus type 1 (HTLV-1) is found in indigenous peoples of the Pacific Islands and...
Human T-lymphotropic virus type 1 (HTLV-1) is found in indigenous peoples of the Pacific Islands and...
BACKGROUND: There is difficulty in gathering data on the prevalence of human T-cell lymphotropic vi...
Introduction The prevalence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1/2) infection is...
Abstract. Dermatologic manifestations are quite common in patients with adult T cell leukemia/lympho...
Human T-lymphotropic virus type 1/2 (HTLV-1/2) infection is endemic in Brazil but representative don...
It is unknown whether HTLV-1/2 prevalence has been stable or changing with time in Brazil. We presen...
Background: Human T-cell lymphotropic virus type 1 (HTLV-1) infection can increase the risk of devel...
Abstract Human T-lymphotropic virus (HTLV) infection has a worldwide distribution and currently, mor...
Background Human T-cell lymphotropic virus type 1 (HTLV-1) infection can increase the risk of develo...
Background. Infective dermatitis associated with human T-cell lymphotropic virus type 1 (HTLV-1; IDH...
Salvador (BA, Brazil) is an endemic area for human T-cell lymphotrophic virus type 1 (HTLV-1). The o...
Salvador (BA, Brazil) is an endemic area for human T-cell lymphotrophic virus type 1 (HTLV-1). The o...
p.761-764Salvador (BA, Brazil) is an endemic area for human T-cell lymphotrophic virus type 1 (HTLV-...
Introduction: Brazil has a high number of HTLV-1/2 infections which are unequally distributed in the...
Human T-lymphotropic virus type 1 (HTLV-1) is found in indigenous peoples of the Pacific Islands and...
Human T-lymphotropic virus type 1 (HTLV-1) is found in indigenous peoples of the Pacific Islands and...
BACKGROUND: There is difficulty in gathering data on the prevalence of human T-cell lymphotropic vi...